Related Experiment Video
Updated: Sep 9, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Immune-Related Comorbidities in Pediatric Familial Mediterranean Fever: A Hidden Burden beyond Autoinflammation
Fatih Eren1, Sefika Ilknur Kokcu Karadag2, Alisan Yıldıran3
1Department of Pediatrics, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Insights
A significant portion of pediatric Familial Mediterranean Fever patients exhibit immune-related comorbidities, often presenting with atypical symptoms. Early immunologic assessment is crucial for identifying these cases and improving treatment outcomes.
Area of Science:
- Pediatric Rheumatology
- Clinical Immunology
- Genetics
Background:
- Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
- Immune-related comorbidities in pediatric FMF are not well-characterized.
- Understanding these comorbidities can refine diagnostic and therapeutic approaches.
Purpose of the Study:
- To determine the frequency of immune-related comorbidities in children with FMF.
- To analyze the clinical and immunologic characteristics of these patients.
- To compare patients with and without comorbidities.
Main Methods:
- A cohort study of 132 pediatric FMF patients at a tertiary care center.
- Stratification into groups based on the presence of immune-related comorbidities.
- Comparative analysis of clinical data, laboratory parameters, MEFV mutations, and treatments.
Main Results:
- Immune-related comorbidities were found in 37.8% of patients, including inborn errors of immunity.
- Comorbidity group showed more atypical symptoms (diarrhea, rash) and less classical FMF symptoms.
- Strong ANA positivity and immunoglobulin deficiencies were linked to comorbidities; intravenous immunoglobulin was used exclusively in this group.
Conclusions:
- Pediatric FMF patients can have immune dysregulation beyond autoinflammation.
- Immunologic assessment is vital for FMF patients with atypical symptoms or poor colchicine response.
- Early identification and intervention can enhance outcomes in this subgroup.
Introduction:
The aim of the study was to assess the frequency and clinical-immunologic characteristics of immune-related comorbidities in children with genetically confirmed familial Mediterranean fever.
Methods:
This cohort study included 132 pediatric patients with a genetically confirmed diagnosis of FMF, followed at a tertiary care center. Patients were stratified into two groups based on the presence or absence of immune-related comorbidities. Clinical manifestations, laboratory parameters, MEFV mutation profiles, and treatment modalities were comparatively analyzed. Statistical significance was set at p < 0.05.
Results:
Immune-related comorbidities were identified in 37.8% of patients, including 12 with defined inborn errors of immunities. These patients more frequently presented with atypical symptoms such as diarrhea, rash, aphthous stomatitis, and appetite loss, while classical symptoms like fever and abdominal pain were less common. Tonsillitis was significantly more frequent in the non-comorbidity group (p = 0.046). Strong antinuclear antibody positivity and immunoglobulin deficiencies were significantly associated with the comorbidity group. Although MEFV mutation patterns did not differ between groups, intravenous immunoglobulin therapy was administered exclusively in patients with immune-related comorbidities (p < 0.001).
Conclusion:
A notable subset of pediatric familial Mediterranean fever patients demonstrates immune dysregulation extending beyond innate autoinflammation. These findings underscore the importance of immunologic assessment in patients with atypical features or inadequate response to colchicine. Early identification and appropriate immunomodulatory interventions may improve clinical outcomes in this distinct subgroup.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
Pericarditis III: Medical Management
Pericarditis I: Introduction

